These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4654779)
1. [Pharmacologic analysis of a new case of postanoxic intention and action myoclonus]. Lhermitte F; Marteau R; Degos CF Rev Neurol (Paris); 1972 Feb; 126(2):107-14. PubMed ID: 4654779 [No Abstract] [Full Text] [Related]
2. [Pharmacological analysis of a case of postanoxic intention and action myoclonus]. Lhermitte F; Peterfalvi M; Marteau R; Gazengel J; Serdaru M Rev Neurol (Paris); 1971 Jan; 124(1):21-31. PubMed ID: 4935256 [No Abstract] [Full Text] [Related]
3. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity. Anderson EG; Baker R; Banna N Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499 [No Abstract] [Full Text] [Related]
4. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors]. Hassler R; Bak IJ Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176 [No Abstract] [Full Text] [Related]
5. Beneficial effects of serotonin precursors in postanoxic action myoclonus. De Léan J; Richardson JC; Hornykiewicz O Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968 [TBL] [Abstract][Full Text] [Related]
6. The effects of monoamine oxidase inhibitors on spinal synaptic activity. Anderson EG; Baker RG; Banna NR J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660 [No Abstract] [Full Text] [Related]
8. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice. Saavedra JM; Fischer E Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068 [No Abstract] [Full Text] [Related]
9. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
10. [Epilepsy and monoamines in the brain]. Kobayashi K; Mori A Nihon Rinsho; 1975 Oct; 33(10):3074-84. PubMed ID: 1107618 [No Abstract] [Full Text] [Related]
11. Is the tonic decerebrate inhibition of reflex paths mediated by monoaminergic pathways? Engberg I; Lundberg A; Ryall RW Acta Physiol Scand; 1968; 72(1):123-33. PubMed ID: 4297709 [No Abstract] [Full Text] [Related]
12. [Effect of monoamine oxidase inhitors on M-serotonin reactive structures of the superior cervical ganglion in cats]. Gilëv AP; Kurilenko VM Farmakol Toksikol; 1966; 29(6):665-8. PubMed ID: 6000362 [No Abstract] [Full Text] [Related]
13. Yohimbine: behavioral and biochemical effects in mice. Sanghvi I; Gershon S Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277 [No Abstract] [Full Text] [Related]
14. [Effect of serotonin on the volume rate of coronary blood circulation in cats under isolated conditions in relation to monoamine oxidase inhibitors]. Gilev AP; Solonenko EL Farmakol Toksikol; 1967; 30(6):678-81. PubMed ID: 5598434 [No Abstract] [Full Text] [Related]
15. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Chadwick D; Hallett M; Jenner P; Marsden CD Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645 [No Abstract] [Full Text] [Related]
16. [Effect of peripheral serotonin antagonists and monoamine oxidase inhibitors on some central effects of indolalkylamines]. Gilev AP; Tetenchuk EV Farmakol Toksikol; 1968; 31(2):159-63. PubMed ID: 5674667 [No Abstract] [Full Text] [Related]